Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Breast Cancer Health Center

Font Size

Frequent Chemo Ups Breast Cancer Survival

Reduces Cancer Recurrence With No More Side Effects


The benefits of the dose-dense regimen were expected to increase over time, says researcher Marc L. Citron, MD, clinical professor of medicine at Albert Einstein College of Medicine in New York.

The idea behind dose-dense dosing is simple: Giving the drugs more frequently doesn't give the cancer as much time to grow between treatments. Thus, each time you treat, you're treating a smaller and smaller amount of cancer.

But for years, doctors were reluctant to try the dose-dense regimen. The reason: Frequent chemotherapy can cause the number of white blood cells to decline -- a condition that increases the risk of serious infection.

But the development of drugs that increase the number of white blood cells in women undergoing chemotherapy has changed all that, the researchers said.

In fact, women on the dose-dense regimens were given such a drug and were less likely to develop a low white blood-cell count, the study showed.

Other side effects were equally common among women on both regimens.

"The bottom line is that the data suggest you can accomplish the same or better in terms of outcome by decreasing the interval between treatments," says William Gradishar, MD, associate professor of medicine at Northwestern University and another study researcher. "For patients with early breast cancer, this should be considered a standard of care."

Jeffrey Abrams, MD, who heads breast cancer trials at the National Cancer Institute, cautions that until the findings are confirmed in future studies, it is too soon to say whether a dose-dense chemotherapy regimen should be the new standard of care.

Nevertheless, he added, the reduced risk of recurrence and death, coupled with the low occurrence of side effects, are encouraging.

1 | 2

Today on WebMD

Breast Cancer Overview
From self-exams and biopsies to reconstruction, we’ve got you covered.
Dealing with breast cancer
Get answers to your questions.
woman having mammogram
Experts don’t agree on all fronts, but you can be your own advocate.
woman undergoing breast cancer test
Many women worry. But the truth? Most abnormalities aren’t breast cancer.
Breast Cancer Treatments Improving
Resolved To Quit Smoking
Woman getting mammogram
Screening Tests for Women
ovarian cancer overview slideshow
serious woman
what is your cancer risk
10 Ways to Revitalize Slideshow